Obexelimab
ZB012-03-001
Phase 3 small_molecule active
Quick answer
Obexelimab for IgG4 Related Disease is a Phase 3 program (small_molecule) at Zenas BioPharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zenas BioPharma
- Indication
- IgG4 Related Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active